Novartis US’ Post

View organization page for Novartis US, graphic

88,421 followers

Risk of cancer recurrence remains a concern for individuals living with breast cancer, regardless of nodal involvement. There is a strong need for effective and tolerable treatment options. At #ASCO2024, we’re highlighting the latest NATALEE analysis of patients with N0 #earlybreastcancer at high risk of recurrence, who have limited options when it comes to further reducing their chances of cancer coming back. #NovartisNews

USA and international Research .

Chief Executive Officer at USA and International Research Inc.

1mo

Addressing the needs of early breast cancer patients is crucial. Looking forward to learning more about the NATALEE analysis and potential breakthroughs at ASCO2024! #ASCO2024 #BreastCancerAwareness

Like
Reply

To view or add a comment, sign in

Explore topics